Conférences - Pharmacologie et développement des médicaments - États-Unis

Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

1.
 
Managing Your FDA Inspection: Before, During and After
ID
876742
Dates
23 mar 2017 - 24 mar 2017
Lieu
Chicago, États-Unis
Résumé
FDA inspects many different kinds of firms. If the FDA regulates your product, they can show up at your lobby and say, “I am here to conduct an inspection.” What do you do? What have you done to prepare for an inspection? How do you deal with the investigator, including their personality? The scary part is having to explain the error of your ways to the FDA and above all, managing an administrative action, e.g., Warning Letter or Import Alert, or a legal action, e.g., civil money penalties, seizure, injunction or prosecution. This course will help you need to know and what you should do to survive an FDA inspection with the least possible pain.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
FDA inspection seminar, FDA inspection, FDA 483, FDA warning letter, FDA investigator, FDA law, Regulatory Sanctions used by FDA, Prohibited Acts
2.
 
Creating FDA Compliant SOPs — FDA Compliant SOPs for Regulated Industry: How to Create High Quality SOPs that Your Team and FDA Auditors Will Love
ID
879364
Dates
23 mar 2017 - 24 mar 2017
Lieu
Boston, États-Unis
Résumé
SOP deficiencies are one of the top 5 findings in FDA audits. The entire Quality Management System (QMS) of an organization could be severely compromised due to SOP defects. Formal written Standard Operating Procedures (SOPs) are required both by the FDA and EMA. Almost every deficiency identified in FDA’s 483s and Warning Letters can be traced back to deficiencies in SOPs at an organization. SOPs are often inadequate, miss important elements, do not contain important tools to increase compliance with the SOPs and, many times, are hard for the personnel who follow them to understand. This workshop is applicable to all FDA-regulated organizations: clinical trials, manufacturing, advertisement, marketing, regulatory affairs, auditing, and laboratory testing.
Contact
Peter Brown;     Tél.: [+1 410 501 5777];     Email.: pbrown@fdamap.com
Sujets
FDA SOP, FDA Compliance, FDA Audit, FDA Inspection, FDA Regulations, FDA 483, FDA Warning Letters, Standard Operating Procedures
3.
 
Keystone Symposia - HIV Vaccines
ID
825258
Dates
26 mar 2017 - 30 mar 2017
Lieu
Steamboat Springs, Colorado, États-Unis
Résumé
Despite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
HIV Vaccines, HIV, natural infection, transmission biology, immunogen platforms, b-cells, t-cells,
Sujets apparentés
4.
 
Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)
ID
876800
Dates
30 mar 2017 - 31 mar 2017
Lieu
Tampa, États-Unis
Résumé
The globalization of the pharmaceutical supply chain has led increased us of Contract Manufacturing Organizations (CMOs). The use of CMOs provides many benefits; however, it can present unique compliance risks, particularly since the operations are not in your facility and therefore not under your direct control. The compliance risks are highlighted by FDA Warning Letter trends, the majority of which are related to serious compliance and data integrity issues at foreign CMO sites.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
contract manufacturing pharmaceutical, CMO Oversight in Pharma Industry, CMO compliance, CMO business model, CMO Qualification Audit
5.
 
Understanding the Statistical Considerations for Quantitative ICH Guidelines
ID
876873
Dates
30 mar 2017 - 31 mar 2017
Lieu
Orlando, États-Unis
Résumé
This course is designed to introduce to individuals the understanding and interpretation of the statistical concepts with reference to certain quantitative ICH Guidelines that apply across laboratory (drug development) and clinical development (drug/device) procedures such as analytical methods in validation and acceptance criteria in calibration procedures, risk management and process monitoring as well as dealing with uncertainties and other relevant issues. It is not a course in statistics but introduces the participant to a hands on approach to the statistical techniques one uses, how they are applied and reasonably interpreted and understood. One will address the various challenges facing pharmaceutical and biotechnology companies when it comes to quantifying results in a meaningful interpretable manner through tabulations and graphical presentations. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Statistical considerations for quantitative ich guidelines training, quantitative measurement procedures, sensitivity of the sample size
6.
 
US GCP Fundamentals for Pharmaceutical and Biologic Companies
ID
876721
Dates
20 avr 2017 - 21 avr 2017
Lieu
San Francisco, États-Unis
Résumé
Good Clinical Practice (GCP) is a term used to describe a collection of various FDA regulations that govern the conduct of clinical trials. It includes regulations which apply to Sponsors and Contract Research Organizations (CROs) who run the trials, the clinical trial sites and Investigators who conduct the research, the Institutional Review Boards (
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
FDA GCP inspections, good clinical practices seminar, GCP compliance, clinical trial sites, IRBs, good manufacturing practice, GMP, FDA inspection management
7.
 
FDA Scrutiny of Promotion and Advertising Practices
ID
876783
Dates
20 avr 2017 - 21 avr 2017
Lieu
Tampa, États-Unis
Résumé
If you go
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
fda's advertising and promotion requirements, fda regulations for labelling, fda warning letter, fda legal authority, ftc, mass media, doj, off label, fda guidance
8.
 
eCTD Submissions Seminar — eCTD Submissions of IND and NDA/BLA to the US FDA: Hands-on Workshop
ID
882700
Dates
20 avr 2017 - 21 avr 2017
Lieu
Boston, États-Unis
Résumé
Starting 5 May 2017, FDA will require all DMFs be submitted only in the electronic CTD format creating a huge burden on owners of most submissions. Converting to eCTD format requires special skills, software and resources, the cost of which could be prohibitive to small manufacturers. Our speaker, Dr. Mukesh Kumar, in this workshop will go over the details of the latest guidance on eCTD submission and explain the key takeaways. The trainers will use their own case studies of how eCTD submissions were created and successfully submitted to the FDA using indigenous tools and expertise. Also discussed will be logistical issues associated with managing and maintaining eCTD compliance with regards to all regulatory submissions. This workshop will be beneficial to both the novices and experienced in the field.
Contact
Peter Brown;     Tél.: [410-501-5777];     Email.: pbrown@fdamap.com
Sujets
eCTD Submission, eCTD Workshop, eCTD Guidance, FDA Submission, FDA Regulations, FDA eCTD Compliance, FDA Compliance
9.
 
DCH — 12th Annual Drug Discovery Chemistry
ID
883331
Dates
23 avr 2017 - 27 avr 2017
Lieu
San Diego, Californie, États-Unis
Résumé
Cambridge Healthtech Institute's 12th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent meeting tracks. New for 2017 is the addition of a Part 2 to the always popular Protein-Protein Interactions, a track on GPCR-Targeted Drug Design, and a symposium on Small Molecules for Cancer Immunotherapy.
Contact
Tél.: [781-972-5400];     Email.: chi@healthtech.com
Sujets
Inflammation Inhibitors, Protein-Protein Interactions, GPCR-Targeted Drug Design, Blood-Brain Penetrant Inhibitors, Kinase Inhibitor Chemistry, Fragment-Based Drug Discovery, Macrocyclics and Constrained Peptides, Small Molecules for Cancer Immunotherapy, Biophysical Approaches for Drug Discovery
10.
 
AMS — 14th Annual Strategic Alliance Management
ID
883404
Dates
01 mai 2017 - 03 mai 2017
Lieu
Philadelphia, PA, États-Unis
Résumé
The successful development of new medicines and combinations is becoming increasingly reliant on harnessing an alliance ecosystem. As the rate of pharmaceutical and biotech partnering continues to rise, alliance management, and the development of an organization’s alliance capability, have evolved into critical components for successful execution and maximized value of each partnership. Yet alliance managers are often confronted with myriad challenges, including managing increasingly complex and distinct types of partnerships, dealing with integrations or divestments, overcoming corporate and cultural diversity, as well as navigating organizational restructuring, team turnover and partnership termination. The need for effective methods to systematically manage biopharma partnerships throughout their entire lifecycle continues to drive and shape the discipline of alliance management. Cambridge Healthtech Institute’s 14th Annual Strategic Alliance Management Congress, May 1-3, brings together senior alliance management, business development, technology transfer and licensing professionals, to network, share experiences, discuss case studies, and share the components that cultivate successful partnerships. Delegates will gain strategic insights, proven tools, methods, and perspectives from a variety of leaders advancing the art of alliance management.
Contact
Tél.: [781-972-5400];     Email.: chi@healthtech.com
Sujets
Pharmaceutical Deal-Making, Alliance Management, Alliance Termination, Alliance Management Initiatives, Case Studies, Manufacturing Partnerships
Sujets apparentés
11.
 
Keystone Symposia - Modeling Viral Infections and Immunity
ID
825364
Dates
01 mai 2017 - 04 mai 2017
Lieu
Estes Park, Colorado, États-Unis
Résumé
Viral infection modeling has provided insights into the pathogenesis and treatment of HIV, HCV, HSV-2, CMV and other viruses. It has had impact in revealing the lifespan of infected cells, how rapidly virus is produced and cleared from the circulation, and the means for evaluating the effectiveness of antiviral treatments. HIV remains a global health threat and there is great interest in revealing features of the main HIV reservoir, latently infected cells and mechanisms of reducing the size of this reservoir by pharmacological means. Other important gaps in knowledge revolve around the cell-mediated and humoral immune responses to HIV, important for generating vaccines and broadly neutralizing antibodies as therapeutics, topics that will be discussed. Further, viral infections generally occur in tissues and thus the meeting will discuss imaging techniques and methods of modeling and analyzing spatial infection data, the role of tissue-resident memory cells, and important features of immune regulation, such as immune exhaustion, cytokine signaling between cells, and viral subversion of innate responses and escape from adaptive responses. The meeting will highlight what we believe are significant hurdles to curing viral infections and will bring together experimental virologists, physician scientists and modelers of various types and experience, groups that do not normally meet. It should foster new collaborations between experimentalists and theoreticians, and between theoreticians working on different viral infections or different aspects of viral infections, as well as help young scientists formulate new research directions and make connections with established senior scientists.
Contact
Tél.: [1 800-253-0685];     Email.: info@keystonesymposia.org
Sujets
modeling viral infections, immunity, viral infection, Modeling Immune Regulation, HIV, Modeling Cellular Immune Responses, Spatial Aspects of Infection
Sujets apparentés
12.
 
Navigating the Maze for Post-Market Compliance -- Complaint Handling, MDRs, Recalls and Proposed Guidance on FDA Risk Benefits
ID
878115
Dates
04 mai 2017 - 05 mai 2017
Lieu
Pittsburgh, États-Unis
Résumé
This interactive one and a half day course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief, who has more than 36 years’ experience with the FDA will provide the participants tools to minimize risk of regulatory enforcement actions. During the seminar, Ms. Hoffman will explain proper handling of complaints reportable or non-reportable, product complaint handling and documentation, how and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall. She will also discuss how to conduct a correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall and key factors in implementing and maintaining compliance with the regulations and real life experiences of FDA. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
medical device recalls seminar, medical device regulations seminar, medical device reporting, medical device complaint management, medical device complaint handling
13.
 
E&L USA 2017 — Extractables & Leachables USA 2017
ID
854250
Dates
09 mai 2017 - 11 mai 2017
Lieu
Falls Church, VA, États-Unis
Résumé
Extractables and leachables examination is continuously growing in importance. Given the current scruitny paid by governing bodies including the FDA and EMEA, understanding the best practice and guidelines to carry out extractables and leachables studies is imperative in order to eliminate risk and potential development delays.
Contact
Emma Nweton;     Tél.: [+44 (0) 1372 802016];     Email.: enewton@smithers.com
Sujets
extractables, leachables, analytical chemistry, pharmaceuticals, drug development, drug delivery, regulations, quality assurance, single-use systems, risk assessments, packaging, drug packaging
14.
 
PV (Pharmacovigilance) Audit Strategy Planning - A Practical Approach to Design and Implementation
ID
878158
Dates
11 mai 2017 - 12 mai 2017
Lieu
San Francisco, États-Unis
Résumé
The European Medicines Agency's (EMA) Guideline on good pharmacovigilance practices (GVP), Module IV requires that risk-based audits of the quality system be performed at regular intervals to assure that it complies with the established quality requirements and to determine its effectiveness. It includes audit of the pharmacovigilance system which is covered by the quality system. The GVP Modules are applicable to EU-based companies and any company marketing medicinal products on a global basis. The legally required risk based audit strategy shall cover all PV processes and tasks undertaken by or delegated to other departments, MAH affiliates, and third parties such as distributors, external service providers, partners (the PV Universe). The PV Audit Strategy Plan is used to prepare the PV audit program, i.e. annual PV Audit Schedule. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
PV Audit Strategy Planning, The European Medicines Agency's (EMA) Guideline, Good Pharmacovigilance Practices (GVP), risk-based audits, GVP Modules, PV Universe
15.
 
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)
ID
878168
Dates
15 mai 2017 - 16 mai 2017
Lieu
Boston, États-Unis
Résumé
The Process Validation Guidelines (January 2011) and the EU Annex 15: Qualification and Validation (October 2015) outline the general principles and approaches the two regulatory bodies consider appropriate elements of process validation for the manufacture of human and animal drugs and biological products, including Active Pharmaceutical Ingredients (APIs). These guidances align Process Validation activities with a product lifecycle concept and with existing FDA and EU guidances, including the FDA/International Conference on Harmonization (ICH), Guidance for Industry, Q8 (R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The lifecycle concept, new to these Guidances, link product and process development, qualification of the commercial manufacturing process, and maintenance of the process in a state of control during routine commercial production. These guidances also support process improvement and innovation through sound science and risk management. The new Process Validation Guideline/Practice incorporate elements of Process Validation as early as the Research and Development phase, and continues onward through Technology Transfer, into the Phase 1 IND Clinical Trial manufacturing phase, and ultimately into Phase 2 and 3, and then commercial manufacturing. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
FDA Process Validation Guidance, EU Annex 15, Active Pharmaceutical Ingredients (APIs), International Conference on Harmonization (ICH)
16.
 
Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC)
ID
878112
Dates
16 mai 2017 - 17 mai 2017
Lieu
Philadelphia, États-Unis
Résumé
This interactive one-and-a-half-day seminar is intended to educate regulatory and quality professionals regarding the rather complicated regulations that distinguish Non-prescription Drugs from other products such as foods, cosmetics, dietary supplements and prescription drugs that sometimes contain the same ingredients. Recent FDA actions such as the banning of antibacterial soaps and ongoing programs that may impact manufacturers and private label distributors will be discussed. It will explain differences in the way homeopathic and conventional drugs are regulated and update participants on FDA’s application of GMP regulations to manufacturing low risk drugs that could be sold as cosmetics with the same ingredients, but different labeling. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Cosmeceuticals, dietary supplements, cosmetics, homeopathic OTCs, FDA regulations, FDA GMPS, good manufacturing practices, over the counter, low risk OTC drugs, warning letters, FDA enforcements actions, FDA marketing regulations
17.
 
Quality Control Laboratory Compliance - cGMPs and GLPs
ID
878196
Dates
18 mai 2017 - 19 mai 2017
Lieu
Philadelphia, États-Unis
Résumé
FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency’s evaluation of the compliance status of regulated companies representing multiple industries - pharmaceuticals, biologics, medical devices, as well as foods and cosmetics - as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Quality Control Lab regulations, QC Lab regulations, FDA QC Lab requirements, FDA lab regulations, Good Laboratory Practices, GLP, cGMP, Current Good Manufacturing Practices
18.
 
Biopharmaceutical Test Method, Methods from Cradle to Grave - Technical, Regulatory & Business Considerations
ID
883756
Dates
18 mai 2017 - 19 mai 2017
Lieu
New Jersey, États-Unis
Résumé
There are progressing expectations for analytical methods as biopharmaceuticals progress from concept to commercialization. Methods touch on more than 40 activities including regulatory submissions, driving manufacturing decisions, product release, method transfer, comparability studies, etc. While there are certain defined regulatory expectations around biopharmaceutical methods (e.g., validated prior to filing BLA) there are also numerous areas where regulatory and industry consensus is lacking (e.g., method qualification). Method issues can impact product approval, product availability, cost of method development, and cost of production.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
biopharmaceutical analytical methods program, regulatory submission, method transfer, comparability studies, analytical method requirements
19.
 
Efficient Process Validation Strategies and Validation Master Plan (VMPs) for Medical Devices
ID
883700
Dates
18 mai 2017 - 19 mai 2017
Lieu
Boston, États-Unis
Résumé
This two day course provides the fundamental knowledge needed to comply with the FDA's cGMP QSR, ISO, and International Medical Device Regulators Forum (IMDRF) (formerly GHTF) requirements for process validation and offers practical advice on how to develop and implement an efficient and effective validation program. Attendees will learn what, when, why, and how to conduct process validation in compliance with FDA and international agency regulations. Additional topics covered in the course include how to develop pragmatic protocols, maintaining satisfactory validation documentation, how to define and perform the IQ/OQ/PQ validation sequence, analysis of trending data, and evaluating the need for re-validation.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
medical devices process validation strategies, FDA's cGMP QSR, international medical device regulators forum (IMDRF) requirement, IQ/OQ/PQ validation sequence
20.
 
Radiation Sterilization of Medical Products - Beyond the Basics
ID
883754
Dates
23 mai 2017 - 24 mai 2017
Lieu
Mahwah, États-Unis
Résumé
This two day highly interactive course will cover all aspects of radiation sterilization validation, materials selection and processing implementation. This workshop has been designed to help attendees learn the ins and outs of all the radiation modalities, materials selection, and validation of the sterilization process per ISO 11137. Additionally, 483 case studies will explore how to avoid the operational and legal issues that arise from nonconformance with regulators (FDA) and auditors. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Contact
Referral;     Tél.: [8887172436];     Email.: referral@complianceonline.com
Sujets
Radiation sterilization for medical devices, sterilization validation, gamma radiation sterilization, E-beam sterilization, X-ray sterilization, irradiator designs
21.
 
Pre-Filled Syringes West Coast
ID
877316
Dates
05 jui 2017 - 06 jui 2017
Lieu
San Diego, États-Unis
Résumé
SMi Group are thrilled to announce the return of Pre-Filled Syringes West Coast 2017 which arrives to California on June 5th & 6th.

Following on from sell-out shows in Europe and Boston, Pre-Filled Syringes West Coast will once again gather a global audience of medical device experts and PFS industry leaders to discuss new developments and showcase cutting edge advances, keeping you at the forefront of a booming industry. The competitive PFS market has sparked great improvements as devices strive for higher quality, safety, and patient satisfaction. Innovation and excellence is requested at every level making Pre-Filled Syringes West Coast the perfect platform to strengthen knowledge in key principles such as human factor engineering, manufacturing and complex biologics, whilst honing in on emerging trends for parenteral devices, including auto injectors, pens, pumps and smart devices. We will also be welcoming expertise from the likes of Nemera, Nipro PharmaPackaging, Terumo, Worrell, Zeon, Allergan, MedImmune, Xeris Pharmaceuticals, Amgen, Eli Lilly, Genentech, Ferring, Roche and more.

Contact
Teri Arri;     Tél.: [+44 (0)20 7827 6000];     Email.: tarri@smi-online.co.uk
Sujets
prefilled syringe, pre-filled syringe, autoinjector, human factors, device development, innovation, strategy, extractables, leachables, patient safety, compliance, biosimilar, parenteral, packaging, combination products, lyophilisation, freeze drying, injectable, injectable devices, syringe, extractables and leachables, E&L, PFS, drug device, drug delivery, combination products, sterilization, needle, component, glass syringe, cop syringe, container, formulation, device development, human factors, manufacturing, device technology, medical device, parenteral drug, plastic, qbd, drug delivery, infusion, vial, cop, sterilization, clogging
22.
 
WPC — 16th Annual World Preclinical Congress
ID
883476
Dates
12 jui 2017 - 16 jui 2017
Lieu
Boston, MA, États-Unis
Résumé
World Preclinical Congress focuses on the very latest trends and technologies impacting preclinical drug discovery and development. World Preclinical Congress 2017 offers a unique opportunity for chemists, biologists, pharmacologists and translational scientists in industry and academia to come together with technology providers to network and collaborate. Coverage includes conferences and short courses on topics including: Medicinal Chemistry, Oncology, Screening, 3D Models, CRISPR, CNS, Drug Toxicity and Blood-Brain Barrier.
Contact
Tél.: [781-972-5400];     Email.: chi@healthtech.com
Sujets
Medicinal Chemistry, Oncology, Screening, Discovery & Development
23.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858795
Dates
13 jui 2017 - 15 jui 2017
Lieu
Chicago, États-Unis
24.
 
FASEB SRC — From Unfolded Proteins in the Endoplasmic Reticulum (ER) to Disease
ID
871055
Dates
18 jui 2017 - 23 jui 2017
Lieu
Saxtons River, VT, États-Unis
Résumé
This SRC focuses on the endoplasmic reticulum (ER) and its functions. The purpose of the meeting is to merge recent developments in molecular biology, cell biology, genetics, and physiology aimed at unraveling the complexities of secretory protein folding, ER stress pathways, lipid signaling, and ER membrane biology, and how failure of these processes lead to pathologies and disease. This SRC will include talks from outstanding scientists, both invited and selected from poster abstracts. The meeting is known for its active discussions, not only during the presentation session, but also during the free afternoons, and especially during the poster sessions. Posters will remain on display during most of the conference and a selection will be advertised in oral poster pitches. The venue, Vermont Academy, is excellently suited for the mingling of junior and established scientists, which will be strengthened by meet-the-speaker sessions that allow discussions of both career issues and science.
Contact
FASEB SRC Staff;     Tél.: [3016347010];     Email.: src@faseb.org
Sujets
biochemistry, Pharmacology
Sujets apparentés
25.
 
Antiviral Drugs Research & Development
ID
882536
Dates
13 jul 2017 - 14 jul 2017
Lieu
Baltimore, États-Unis
Résumé
We invite you to attend and engage with other prominent thinkers in the field Antiviral Drugs Research & Development on July 13-14, 2017 in Baltimore, MD.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
Sujets
Session Topics: Plenary Session: Responding to Emerging Infectious Diseases on the Global Stage Respiratory Viral Infections: Current Landscape and Emerging Drugs Blood Borne Pathogens: New Frontiers in Research and Drug Development Regulatory Challenges on Clinical Study Design and Considerations Panel: New Approaches to Antiviral Development General Session: Public/Private Partnerships in Support of Global Health
Sujets apparentés
26.
 
Vaccines Research & Development
ID
884878
Dates
13 jul 2017 - 14 jul 2017
Lieu
Baltimore, États-Unis
Résumé
GTCbio’s 15th Annual Vaccines Research & Development Conference will take place July 13-14, 2017 in Baltimore, MD as part of the larger Infectious Diseases Summit.
Contact
Kristen Starkey;     Tél.: [6262566405];     Email.: infogtcbio@gtcbio.com
Sujets
Vaccines, Infectious Diseases, Enhancing Immunity
27.
 
9th International Conference and Exhibition on Pharmacovigilance & Drug Safety
ID
869764
Dates
17 jul 2017 - 19 jul 2017
Lieu
Munich, États-Unis
Contact
programe cordinator;     Tél.: [702-508-5200];     Email.: pharmacovigilance@pharmaceuticalconferences.org
Sujets
Advanced Regulatory Compliance in Pharmacovigilance operations and innovations Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
28.
 
International Vaccines Congress
ID
857235
Dates
27 jul 2017 - 28 jul 2017
Lieu
Chicago, États-Unis
Résumé
PULSUS is the publisher of peer reviewed scientific, technical, and medical journals and magazines. Since establishment 1984, has been instrumental in healthcare and medical dissemination. PULSUS expanded with the support from scientific societies and open its arm to conduct global medical and healthcare meetings. With immense please and support, PULSUS is honored to announced it International Vaccines Congress, which will be going to held in Chicago, USA during July 27-28, 2017.
Contact
Annah Brwon;     Email.: vaccinescongress@protonmail.com
Sujets
vaccines Congress, Vaccines Conference 2017, Vaccines Conference USA
Sujets apparentés
29.
 
Pharmacology Studies 2017 — International Conference on Pharmacology & Toxicology Studies
ID
859628
Dates
07 aou 2017 - 09 aou 2017
Lieu
Philadelphia, États-Unis
Résumé
Scientific Synergy Conferences are delighted to welcome you all to the
Contact
Scientific Synergy;     Tél.: [+1-888-623-5051];     Email.: pharmacology@scientificsynergy.com
Sujets
Pharmacology Studies 2017, Pharmacology Conference, Toxicology Conference, Scientific Synergy USA, Pharmacology Conference Philadelphia, Pharmacology Congress USA, Clinical Pharmacology event, Drug Toxicology, Pharmacology Case Reports, Forensic Toxicology.
30.
 
Formulation & Drug Delivery USA Congress
ID
871459
Dates
14 sep 2017 - 15 sep 2017
Lieu
Boston, États-Unis
Résumé
Oxford Global are proud to present our Formulation & Drug Delivery USA Congress, taking place on 14 – 15 September 2017 in Boston. Over 150 delegates representing leading pharmaceutical organisations, biotech companies and internationally renowned research & academic institutions will be present to discuss and network. Over 40 case studies and presentations focused on exploring regulatory guidelines of both large and small molecule formulations, future applications of protein and peptide formulations, recent advancements in nanoparticles as drug delivery systems, combination drug delivery devices and improving the bioavailability of compounds.
Contact
Guillaume Alonso;     Tél.: [+44 (0) 1865 248 455];     Email.: g.alonso@oxfordglobal.co.uk
Sujets
drug formulation, drug delivery, small molecules, large molecules
31.
 
ADC — World ADC San Diego 2017
ID
884774
Dates
20 sep 2017 - 22 sep 2017
Lieu
San Diego, États-Unis
Contact
Jenny Barlow;     Email.: info@hansonwade.com
Sujets
antibody drug conjugates, antibody-drug conjugates, bioconjugates, immunoconjugate, protein-drug conjugate, ADCs, PDCs, conjugation, linker, payload, warhead, immunotoxin, antibody formats, antibody engineering, Kadcyla, Adcetris
32.
 
ICCP — 5th International Conference on Clinical Pharmacy
ID
858160
Dates
23 oct 2017 - 24 oct 2017
Lieu
Florida, États-Unis
Résumé
Clinical Pharmacy Conference aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results about all aspects of Clinical Pharmacy. It also provides the disciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Clinical Pharmacy. All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers, and e-posters. Also, high-quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Clinical Pharmacy are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers, and e-posters that address themes and topics of the conference, including figures, tables, and references of novel research material. The conference abstracts and proceedings book and certificate of presentation will be distributed to the conference participants at the conference registration desk. In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of biomedical, pharmaceutical, and clinical sciences by providing a platform for critical analysis of new data, and to share latest cutting-edge research findings and results about all aspects of Clinical Pharmacy.
Contact
Victor Badoni;     Tél.: [7025085200 Ext: 8047];     Email.: badonivictor@outlook.com
Sujets
Pharma Conferences, Pharmacy Conferences, Clinical Pharmacy Conferneces, Pharmaceutical Conferences
33.
 
Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
ID
858895
Dates
31 oct 2017 - 02 nov 2017
Lieu
Boston , États-Unis
34.
 
International Pharmaceutical Conference and Expo
ID
875998
Dates
14 nov 2017 - 16 nov 2017
Lieu
Philadelphia,, États-Unis
Résumé
iPharma 2017 cordially welcomes you to the City of Philadelphia, USA during November 14-16, 2017. Conference will witness academicians and business professionals discussing the soundest issues related to pharmaceuticals and will offer unparalleled business opportunities and access to new markets in Health Science.
Contact
serena martin;     Tél.: [6193784793];     Email.: serena@ipharmaconference.com
Sujets
Pharmaceutical, Drug Discovery, Drug Delivery Systems, Pharmaceutical Nanotechnology, Drug Therapy, Pharmaceutical Formulations, Clinical Trials, Neuropharmacology, Biopharmaceutical, Nutraceuticals, Pharma Medicines
35.
 
Biomarkers congress 2017 — Annual World Congress on Biomarkers & Clinical Research
ID
867828
Dates
27 nov 2017 - 28 nov 2017
Lieu
Atlanta, États-Unis
Résumé
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Contact
Rachel Mathews;     Email.: america@cmesociety.com
Sujets
Biomarkers Conference, Biomarkers Conference 2017, Biomarkers Conference December, Cancer Biomarkers, Cancer Conferences, Cancer Conferences 2017, Biomarkers Events, Biomarkers Society Conferences, Biomarkers Congress
Sujets apparentés
36.
 
Biomarkers Congress 2017 — Annual World Congress on Biomarkers & Clinical Research
ID
884380
Dates
27 nov 2017 - 28 nov 2017
Lieu
Atlanta, États-Unis
Résumé
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Contact
Safina Robinson;     Tél.: [+1-800-982-0387];     Email.: biomarkers@cmesocietyconferences.org
Sujets
Biomarker Conference, Biomarkers Conference 2017, Biomarkers Conferences, Biomarkers Congress, Biomarker Conferences USA, Biomarker Conferences, Biomarkers Congress 2017, Biomarker Conferences 2017, Biomarkers Society Conferences, Biomarkers cme conference
Sujets apparentés

États-Unis: liste de tous les évènements/conférences.

Pharmaceutical Freeze Drying Technology, 8th & 9th May 2017, Copthorne Tara Hotel, London UK
Pain Therapeutics, 22nd & 23rd May 2017, Copthorne Tara Hotel, London UK
Pre-Filled Syringes West Coast, 5th & 6th June 2017, Hyatt Regency Mission Bay, San Diego, California, USA

Bon à savoir...

Vous pouvez insérer un encadré afin de diffuser vos évènements et services dans cet espace.

Dernière mise à jour: 19 Mars 2017